Conference Day Two
Overcoming Product Development Roadblocks Ahead of Commercialization
8:25 am Chairperson’s Opening Remarks
8:30 am Panel Discussion: Overcoming Novel Ingredient Development Challenges to Create More Targeted Nutritional Products
Synopsis
- Outlining the current challenges in developing ingredients and products which target the gut microbiome
- Understanding what steps the industry need to take to overcome such obstacles
9:00 am Mapping the Microbiome’s Link to Nutrition
Synopsis
- One of the principal modifiers of the composition of our microbiome is the food we eat, but we largely do not understand these interactions
- Leveraging a component of Holobiome’s screening platform to map how our food and its ingredients interface with human bacteria
- Exploring how this knowledge can be leveraged to improve food, develop prebiotics, and support probiotics and live biotherapeutic development
9:30 am The Benefits, Strategy & Challenges of Using Genetic Engineering for Product Development
Synopsis
- Outlining genetic engineering as a great way of making differentiated, patentable products with targeted, real, and easily communicable benefits for the consumer
- Exploring the tool of genetic engineering and its potential future impact of the probiotics industry
- Discussing strategies for addressing and overcoming unique technical, regulatory, and consumer challenges associated with genetically engineered probiotics
10:00 am Morning Break
Navigating Formulation & Delivery Considerations to Produce an Effective & Efficient Product
11:00 am Leveraging the Benefits of Dietary Fibre for Cost Effective Treatment & Prevention in Type-2 Diabetes
Synopsis
- Discussing how Myota has leveraged the two main mechanisms of action, namely post-prandial glycaemic response regulation and Short Chain Fatty Acid production by the gut microbiome, to develop precision fibre blends aimed at treating and prevent Type-2 Diabetes
- Outlining the clinical trials currently underway for testing these blends in diabetic populations
11:30 am Exploring Fermented Foods as Microbiome Modulating Nutritional: Impacts on the Gut Microbiome & Metabolome
Synopsis
- The world is awakening to the likely advantages of consuming microbes and their metabolites
- Outlining that while fermented foods are not technically probiotics, that is not to say they are not beneficial
- Exploring part of our research that is interested in microbial therapeutics for various diseases and we believe one potentially under-explored area for this is fermented foods
12:00 pm Lunch Break & Networking
Exploring the Complex Regulatory Landscape: Leverage Your Early Research to Support Product Claims
1:00 pm Understanding What Regulators Want from Your Clinical Trial to Substantiate New Claims: A Case Study
Synopsis
- Exploring the hurdles that still exist in evaluating the health benefits of a product
- The global health authorities have not provided detailed instructions of on how to evaluate the develop clinical trials and evaluate the totality of evidence for claim substantiation
- Discussing the essential elements that should be embraced by clinical trials to make it eligible and desirable for and considerations for the totality of evidence for claim substantiation
1:30 pm Panel Discussion: Exploring Safety Standards for Novel Products: Novel Probiotics & Food Product
Synopsis
- Discussing what steps need to be take to reach a unified framework
- Exploring how the industry can work together to reach stronger health claims
2:00 pm Roundtables: Discussing Regulatory Questions and Outlining Current Regulatory Roadmaps
Synopsis
Have your say on the ever evolving regulatory landscape by taking part in this interactive roundtable discussion session
2:30 pm Afternoon Coffee Break & Networking
Outlining Ingredient & Manufacturing Considerations – Producing High Quality Products
3:00 pm Probiotics Derived from Human Breast Milk: Health Impact in Early Life
Synopsis
- Uncovering probiotic strains isolated from human breast milk
- Reviewing the beneficial effects of these probiotics in neonates
- Revealing new clinical data in preterm infants
3:30 pm Developing Synbiotics for Health Benefits: Challenges & Opportunities
Synopsis
- Discussing synbiotic development using a rational approach
- Exploring the potential for synbiotic based approaches for health benefits
- Considerations for synbiotic product formulation and manufacturing